Iktos

Biotechnology ResearchÎle-de-france, France51-200 Employees

Iktos is a French biotechnology research company based in Paris (65 Rue de Prony, 75017) with 51-200 employees. It focuses on artificial intelligence and robotics applied to medicinal chemistry and small-molecule drug design, offering Makya for generative drug design and Spaya for retrosynthesis as SaaS platforms, along with its AI-driven synthesis automation platform, Iktos Robotics. The company pursues strategic collaborations with pharmaceutical partners to accelerate small-molecule discovery and maintains an internal pipeline targeting oncology and autoimmune/inflammatory diseases. Notable milestones include a March 2023 €15.5 million Series A financing and the July 2024 acquisition of Synsight to add a biology platform for protein-protein and RNA-protein interactions. In 2025 it received an €2.5 million EIC Accelerator grant with potential follow-on funding, and in 2026 announced partnerships with Servier Group and Pierre Fabre Group to advance drug discovery programs.

Sign up for free to view info

Email Format Employee directory